Remediation of Working Memory in Schizophrenia
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00995553 |
|
Recruitment Status :
Completed
First Posted : October 15, 2009
Results First Posted : April 25, 2016
Last Update Posted : April 25, 2016
|
Sponsor:
VA Office of Research and Development
Collaborators:
Veterans Medical Research Foundation
Minneapolis Veterans Affairs Medical Center
Information provided by (Responsible Party):
VA Office of Research and Development
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Brief Summary:
The primary aim of the study is to test the efficacy of a novel cognitive remediation intervention that targets working memory-related functions. To accomplish this goal, 80 volunteer patients with schizophrenia will be enrolled and randomized to either a cognitive remediation condition that targets working memory or a computer skills training intervention that teaches computer applications. In both conditions participants will receive computer training three times a week for 4 months. The investigators hypothesize that patients who receive the cognitive remediation intervention will demonstrate significantly greater change on neuropsychological measures of working memory and executive abilities than patients who receive the computer skills course. In addition, the investigators hypothesize that the intervention-induced cognitive change will be associated with concurrent improvements in functional capacity and psychosocial functioning in the community. A second study goal is to examine the stability of the intervention-induced changes in cognition. Cognition and psychosocial functioning will be reassessed 4 and 8 months after treatment termination to examine the stability of treatment effects and to assess whether a less intense maintenance training (once a week sessions) provides any additional benefit to participants. Lastly, this study will examine in an exploratory manner whether there are individual differences in treatment response. The Val158Met polymorphism of the COMT gene has been found to be associated with working memory and prefrontal dysfunction in schizophrenia. The study will test whether the COMT polymorphism is predictive of response to cognitive remediation.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Schizophrenia Schizoaffective Disorder | Behavioral: Cognitive Remediation Behavioral: Computer Skills | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 86 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Remediation of Working Memory in Schizophrenia |
| Study Start Date : | January 2010 |
| Actual Primary Completion Date : | April 2015 |
| Actual Study Completion Date : | December 2015 |
Resource links provided by the National Library of Medicine
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Cognitive Remediation
A 48-session working memory focused cognitive remediation program is conducted. Training tasks have been selected from 3 software programs, PSS CogRehab, BrainTrain, and custom made N-back tasks.
|
Behavioral: Cognitive Remediation
This is an adaptive, computer-based cognitive training intervention. Participants will complete 3 1-hour cognitive training sessions focused on attention and working memory processes weekly for 4 months. |
|
Placebo Comparator: Computer Skills
This is a 48-session, time matched comparison group in which participants practice keyboarding skills and the fundamentals of Microsoft Office Word, Powerpoint, and Excel programs.
|
Behavioral: Computer Skills
This is a computer-based course in which participants will be taught how to use Microsoft Office applications and typing skills. Participants will attend a 1-hour course three times a week four 4-months. |
Primary Outcome Measures :
- Cognitive Assessment - MATRICS Consensus Cognitive Battery [ Time Frame: Post-intervention, within 2 weeks of completion of the 4 month intervention ]The Working Memory and Attention indexes of the MATRICS Consensus Cognitive Battery was used to assess near generalization of training with untrained tasks that were conceptually similar to training tasks. Each scale provide an age and gender corrected T-score. Thus, scores can range from 0-100, with a higher score indicating better performance.
Secondary Outcome Measures :
- Functional Capacity - University of California, San Diego Performance-Based Skills Assessment [ Time Frame: Post-intervention, within 2 weeks of completion of the 4 month intervention ]The UPSA is a measure of the ability to apply cognitive skills to functional tasks. The total score from this scale was used. Scores may range from 0 - 100, with higher scores being better.
Information from the National Library of Medicine
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 60 Years (Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Veterans with a DSM-IV diagnosis of schizophrenia or schizoaffective disorder
- No hospitalizations in the previous 4 weeks
- No antipsychotic medication changes in the previous 4 weeks
- Age 18-60
- Does not meet DSM-IV criteria for substance dependence in the previous 6 months or substance abuse in the previous month
Exclusion Criteria:
- History of clinically significant head injury or neurological disease
- Poor comprehension of the English language
- History of diagnosis of mental retardation or pervasive developmental disorder
- Unable to give informed consent
Information from the National Library of Medicine
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00995553
Locations
| United States, Minnesota | |
| Minneapolis VA Health Care System, Minneapolis, MN | |
| Minneapolis, Minnesota, United States, 55417 | |
Sponsors and Collaborators
VA Office of Research and Development
Veterans Medical Research Foundation
Minneapolis Veterans Affairs Medical Center
Investigators
| Principal Investigator: | Tasha Marie Nienow, PhD | Minneapolis VA Health Care System, Minneapolis, MN |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT00995553 History of Changes |
| Other Study ID Numbers: |
D6981-R 1I01RX000180-01 ( U.S. NIH Grant/Contract ) |
| First Posted: | October 15, 2009 Key Record Dates |
| Results First Posted: | April 25, 2016 |
| Last Update Posted: | April 25, 2016 |
| Last Verified: | April 2016 |
Additional relevant MeSH terms:
|
Schizophrenia Psychotic Disorders Schizophrenia Spectrum and Other Psychotic Disorders Mental Disorders |